Table 3

First-line tuberculosis treatment-related conditions in MDR-TB cases and their controls in Addis Ababa, 2011
Characteristics Cases Controls
(n = 134) (n = 134)
Number Percentage Number Percentage
Encountered drug side effect
No 67 50.0 109 81.3
Yes 67 50.0 25 18.7
Suffered the most common drug side effect (vomiting)
No 85 63.4 124 92.5
Yes 49 36.6 10 7.5
Duration of first-time TB treatment
2–4 months 3 2.2% 1 0.75%
5–7 months 22 16.4% 2 1.5%
8 months 103 76.9% 128 95.5
9–13 months 6 4.5% 3 2.2%
Directly observed by health worker while taking anti-TB
No 65 48.5 7 5.2
Yes 69 51.5 127 94.8
If yes, how many months
1–2 weeks 11 15.95 0 0
One month 32 46.4 1 0.8
Two months 26 37.7 126 99.2
Reason for interruption for at least a day
Side effects 34 36.6 3 30.0
Forgot to take it 23 24.7 7 70.0
Symptoms were gone and felt good 29 31.2 0 0
Shortage of drug 7 7.5 0 0
Ever interrupted anti-TB for at least a day
No 41 30.6 124 92.5
Yes 93 69.4 10 7.5
Took the medication at a regular time
No 81 60.5 25 18.7
Yes 53 39.5 109 81.3
Outcome of first anti-TB treatment
Treatment success 64 47.7 132 98.5
Defaulted 16 11.9 2 1.5
Treatment failure 54 40.3 0 0
Drug regimen (category) for the second time
Category II 101 94.4 3 23.1
Category I 6 5.6 10 76.9

Hirpa et al.

Hirpa et al. BMC Public Health 2013 13:782   doi:10.1186/1471-2458-13-782

Open Data